ArticleBritish journal of cancer2018

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b.

Cameron E Snell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.